412 related articles for article (PubMed ID: 21419787)
1. 5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test.
Günther L; Rothe J; Rex A; Voigt JP; Millan MJ; Fink H; Bert B
Neuropharmacology; 2011 Sep; 61(3):433-41. PubMed ID: 21419787
[TBL] [Abstract][Full Text] [Related]
2. Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: a comparison of SSR180711 and PNU-282987.
Andreasen JT; Redrobe JP; Nielsen EØ
Pharmacol Biochem Behav; 2012 Jan; 100(3):624-9. PubMed ID: 22108649
[TBL] [Abstract][Full Text] [Related]
3. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
Zhang H; Wang W; Jiang Z; Shang J; Zhang L
Arzneimittelforschung; 2010; 60(3):109-15. PubMed ID: 20422941
[TBL] [Abstract][Full Text] [Related]
4. The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation.
Pytka K; Walczak M; Kij A; Rapacz A; Siwek A; Kazek G; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B
Eur J Pharmacol; 2015 Oct; 764():537-546. PubMed ID: 26210317
[TBL] [Abstract][Full Text] [Related]
5. Implication of 5-HT(2B) receptors in the serotonin syndrome.
Diaz SL; Maroteaux L
Neuropharmacology; 2011 Sep; 61(3):495-502. PubMed ID: 21277875
[TBL] [Abstract][Full Text] [Related]
6. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.
Pałucha-Poniewiera A; Brański P; Lenda T; Pilc A
J Pharmacol Exp Ther; 2010 Sep; 334(3):1066-74. PubMed ID: 20562216
[TBL] [Abstract][Full Text] [Related]
7. Mice over-expressing the 5-HT(1A) receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT.
Bert B; Fink H; Hörtnagl H; Veh RW; Davies B; Theuring F; Kusserow H
Behav Brain Res; 2006 Feb; 167(2):328-41. PubMed ID: 16256213
[TBL] [Abstract][Full Text] [Related]
8. Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.
Egashira N; Matsuda T; Koushi E; Higashihara F; Mishima K; Chidori S; Hasebe N; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
Eur J Pharmacol; 2008 Jul; 589(1-3):117-21. PubMed ID: 18565508
[TBL] [Abstract][Full Text] [Related]
9. Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects.
Bortolozzi A; Castañé A; Semakova J; Santana N; Alvarado G; Cortés R; Ferrés-Coy A; Fernández G; Carmona MC; Toth M; Perales JC; Montefeltro A; Artigas F
Mol Psychiatry; 2012 Jun; 17(6):612-23. PubMed ID: 21808255
[TBL] [Abstract][Full Text] [Related]
10. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
Rénéric JP; Bouvard M; Stinus L
Neuropsychopharmacology; 2001 Apr; 24(4):379-90. PubMed ID: 11182533
[TBL] [Abstract][Full Text] [Related]
11. Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests.
Andreasen JT; Redrobe JP
Behav Brain Res; 2009 Jan; 197(1):150-6. PubMed ID: 18786574
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins.
Moulin-Sallanon M; Charnay Y; Ginovart N; Perret P; Lanfumey L; Hamon M; Hen R; Fagret D; Ibáñez V; Millet P
Synapse; 2009 Feb; 63(2):106-16. PubMed ID: 19016488
[TBL] [Abstract][Full Text] [Related]
13. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C
Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119
[TBL] [Abstract][Full Text] [Related]
14. The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test.
Szewczyk B; Poleszak E; Wlaź P; Wróbel A; Blicharska E; Cichy A; Dybała M; Siwek A; Pomierny-Chamioło L; Piotrowska A; Brański P; Pilc A; Nowak G
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):323-9. PubMed ID: 19150479
[TBL] [Abstract][Full Text] [Related]
15. [Antidepressants, stressors and the serotonin 1A receptor].
Kirilly E; Gonda X; Bagdy G
Neuropsychopharmacol Hung; 2015 Jun; 17(2):81-9. PubMed ID: 26192901
[TBL] [Abstract][Full Text] [Related]
16. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
[TBL] [Abstract][Full Text] [Related]
17. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
Harkin A; Kelly JP; McNamara M; Connor TJ; Dredge K; Redmond A; Leonard BE
Eur J Pharmacol; 1999 Jan; 364(2-3):123-32. PubMed ID: 9932714
[TBL] [Abstract][Full Text] [Related]
18. Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.
Celada P; Bortolozzi A; Artigas F
CNS Drugs; 2013 Sep; 27(9):703-16. PubMed ID: 23757185
[TBL] [Abstract][Full Text] [Related]
19. Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.
Takahashi E; Katayama M; Niimi K; Itakura C
Eur J Pharmacol; 2008 Jul; 589(1-3):149-56. PubMed ID: 18571641
[TBL] [Abstract][Full Text] [Related]
20. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus.
Bermack JE; Haddjeri N; Debonnel G
J Pharmacol Exp Ther; 2004 Aug; 310(2):578-83. PubMed ID: 15044555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
